These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1693 related articles for article (PubMed ID: 36253873)
1. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets. Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873 [TBL] [Abstract][Full Text] [Related]
2. Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas. Wang X; Zhang W; Guo Y; Zhang Y; Bai X; Xie Y World J Surg Oncol; 2023 Feb; 21(1):61. PubMed ID: 36823639 [TBL] [Abstract][Full Text] [Related]
3. Construction of store-operated calcium entry-related gene signature for predicting prognosis and indicates immune microenvironment infiltration in stomach adenocarcinomas. Zhang Z; Wang C; Shi W; Wang Z; Fu W Sci Rep; 2024 Sep; 14(1):22342. PubMed ID: 39333689 [TBL] [Abstract][Full Text] [Related]
4. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma. Liu Z; Liu H; Wang Y; Li Z BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983 [TBL] [Abstract][Full Text] [Related]
5. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma. Han C; Zhang C; Wang H; Li K; Zhao L BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056 [TBL] [Abstract][Full Text] [Related]
6. Construction of a prognostic risk model for Stomach adenocarcinoma based on endoplasmic reticulum stress genes. Li X; Lei Y Wien Klin Wochenschr; 2024 Jun; 136(11-12):319-330. PubMed ID: 37993598 [TBL] [Abstract][Full Text] [Related]
7. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
8. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma. Song Z; Su M; Li X; Xie J; Han F; Yao J BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437 [TBL] [Abstract][Full Text] [Related]
9. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer. Yuan W; Han J; Chen C; Qiu Y; Xu Y; Huang Y; Chen Z; Xu A; Sun M Aging (Albany NY); 2024 Aug; 16(16):12029-12049. PubMed ID: 39181686 [TBL] [Abstract][Full Text] [Related]
10. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients. Zha Z; Zhang P; Li D; Liu G; Lu L Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217 [TBL] [Abstract][Full Text] [Related]
11. A Prognostic Signature Constructed by Han S; Zhu W; Yang W; Guan Q; Chen C; He Q; Zhong Z; Zhao R; Xiong H; Han H; Li Y; Sun Z; Hu X; Tian J Front Genet; 2021; 12():646818. PubMed ID: 34512711 [TBL] [Abstract][Full Text] [Related]
12. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases. Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325 [TBL] [Abstract][Full Text] [Related]
13. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma. He C; Zhu X; Kong F; Zhang X; Chai X; Zou C; Zhao D Biomed Res Int; 2022; 2022():2747799. PubMed ID: 35711526 [TBL] [Abstract][Full Text] [Related]
14. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma. Yue C; Ma H; Zhou Y PeerJ; 2019; 7():e8128. PubMed ID: 31803536 [TBL] [Abstract][Full Text] [Related]
15. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes. Xu HH; Wang HL; Xing TJ; Wang XQ Front Immunol; 2022; 13():851622. PubMed ID: 35924232 [TBL] [Abstract][Full Text] [Related]
16. A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma. Wang T; Chen P; Li T; Li J; Zhao D; Meng F; Zhao Y; Zheng Z; Liu X Curr Med Chem; 2024; 31(17):2378-2399. PubMed ID: 38310388 [TBL] [Abstract][Full Text] [Related]
17. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
18. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer. Wu M; Li X; Zhang T; Liu Z; Zhao Y Front Oncol; 2019; 9():996. PubMed ID: 31612115 [No Abstract] [Full Text] [Related]
19. The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma. Yang B; Wang Y; Liu T; Zhang M; Luo T Aging (Albany NY); 2024 Mar; 16(7):6098-6117. PubMed ID: 38546403 [TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a prognostic model based on stage-associated signature genes of head and neck squamous cell carcinoma: a bioinformatics study. Chen L; Zhang X; Lin J; Wen Y; Chen Y; Chen CB Ann Transl Med; 2022 Dec; 10(24):1316. PubMed ID: 36660709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]